Hangzhou AGS MedTech Co., Ltd. (SHA:688581)
57.53
-0.59 (-1.02%)
At close: Mar 9, 2026
Hangzhou AGS MedTech Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2017 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2017 |
| Cash & Equivalents | - | 1,031 | 1,955 | 213.38 | 204.53 | Upgrade
|
| Short-Term Investments | - | 81.2 | - | - | - | Upgrade
|
| Trading Asset Securities | - | 671.22 | 82.42 | 55.01 | 1.09 | Upgrade
|
| Cash & Short-Term Investments | 1,741 | 1,784 | 2,037 | 268.4 | 205.62 | Upgrade
|
| Cash Growth | -2.40% | -12.44% | 659.01% | 30.53% | 32.06% | Upgrade
|
| Accounts Receivable | - | 48.15 | 58.51 | 18.83 | 12.24 | Upgrade
|
| Other Receivables | - | 0.79 | 1.18 | 2.11 | 2.04 | Upgrade
|
| Receivables | - | 48.95 | 59.68 | 20.95 | 14.28 | Upgrade
|
| Inventory | - | 56.38 | 46.8 | 38.57 | 39.89 | Upgrade
|
| Prepaid Expenses | - | - | 0.05 | 0.1 | - | Upgrade
|
| Other Current Assets | - | 5.42 | 2.45 | 3.88 | 2.78 | Upgrade
|
| Total Current Assets | - | 1,894 | 2,146 | 331.89 | 262.56 | Upgrade
|
| Property, Plant & Equipment | - | 200.09 | 159.7 | 117.67 | 54.89 | Upgrade
|
| Long-Term Investments | - | 432.43 | - | - | - | Upgrade
|
| Other Intangible Assets | - | 18.27 | 19 | 19.72 | 19.95 | Upgrade
|
| Long-Term Deferred Tax Assets | - | 1.24 | 1.9 | 0.36 | 0.3 | Upgrade
|
| Long-Term Deferred Charges | - | 2.77 | 2.35 | 3.3 | 3.18 | Upgrade
|
| Other Long-Term Assets | - | 0.58 | 1.99 | 0.19 | 1.12 | Upgrade
|
| Total Assets | - | 2,550 | 2,331 | 473.13 | 341.99 | Upgrade
|
| Accounts Payable | - | 66.02 | 48.41 | 32.05 | 37.65 | Upgrade
|
| Accrued Expenses | - | 40.84 | 34.79 | 24.29 | 9.13 | Upgrade
|
| Current Portion of Leases | - | 1.3 | 0.57 | 1.08 | 0.94 | Upgrade
|
| Current Income Taxes Payable | - | 17.49 | 14.95 | 15.7 | 6.95 | Upgrade
|
| Current Unearned Revenue | - | 8.28 | 5.14 | 7.15 | 8.77 | Upgrade
|
| Other Current Liabilities | - | 8.05 | 16.88 | 10.76 | 5.56 | Upgrade
|
| Total Current Liabilities | - | 141.99 | 120.73 | 91.03 | 69 | Upgrade
|
| Long-Term Leases | - | 2.15 | - | 0.57 | 1.39 | Upgrade
|
| Long-Term Unearned Revenue | - | 8.53 | 2.1 | - | - | Upgrade
|
| Long-Term Deferred Tax Liabilities | - | - | - | - | 0.16 | Upgrade
|
| Total Liabilities | - | 152.67 | 122.83 | 91.59 | 70.55 | Upgrade
|
| Common Stock | - | 80.98 | 57.87 | 43.4 | 43.4 | Upgrade
|
| Additional Paid-In Capital | - | 1,725 | 1,715 | 76.53 | 76.53 | Upgrade
|
| Retained Earnings | - | 621.87 | 434.79 | 261.54 | 151.62 | Upgrade
|
| Treasury Stock | - | -30.97 | - | - | - | Upgrade
|
| Comprehensive Income & Other | - | 0.1 | 0.11 | 0.07 | -0.1 | Upgrade
|
| Shareholders' Equity | 2,488 | 2,397 | 2,208 | 381.54 | 271.45 | Upgrade
|
| Total Liabilities & Equity | - | 2,550 | 2,331 | 473.13 | 341.99 | Upgrade
|
| Total Debt | 2.58 | 3.45 | 0.57 | 1.64 | 2.32 | Upgrade
|
| Net Cash (Debt) | 1,738 | 1,780 | 2,037 | 266.75 | 203.3 | Upgrade
|
| Net Cash Growth | -2.35% | -12.59% | 663.48% | 31.21% | 30.57% | Upgrade
|
| Net Cash Per Share | 21.61 | 22.09 | 28.06 | 4.39 | 3.35 | Upgrade
|
| Filing Date Shares Outstanding | 78.44 | 80.58 | 81.02 | 60.76 | 60.76 | Upgrade
|
| Total Common Shares Outstanding | 78.44 | 80.58 | 81.02 | 60.76 | 60.76 | Upgrade
|
| Working Capital | - | 1,752 | 2,025 | 240.86 | 193.57 | Upgrade
|
| Book Value Per Share | 30.58 | 29.75 | 27.26 | 6.28 | 4.47 | Upgrade
|
| Tangible Book Value | 2,470 | 2,379 | 2,189 | 361.82 | 251.5 | Upgrade
|
| Tangible Book Value Per Share | 30.35 | 29.52 | 27.02 | 5.95 | 4.14 | Upgrade
|
| Buildings | - | 164.61 | 71.12 | 26.84 | 26.84 | Upgrade
|
| Machinery | - | 52.19 | 41.56 | 7.7 | 28.88 | Upgrade
|
| Construction In Progress | - | 8.65 | 67.92 | 72.65 | 10.55 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.